(Q44204619)

30 November 2017

Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity (English)

1 reference

30 November 2017

0 references

Xin Lu

1

1 reference

30 November 2017

Shimei Gong

2

1 reference

30 November 2017

Anne Monks

3

1 reference

30 November 2017

Daniel Zaharevitz

4

1 reference

30 November 2017

Jeffrey A Moscow

5

1 reference

30 November 2017

1 July 2002

1 reference

Journal of Experimental Therapeutics & Oncology

30 November 2017

1 reference

30 November 2017

2

1 reference

30 November 2017

4

1 reference

30 November 2017

200-212

1 reference

Nucleoside and nucleobase transport systems of mammalian cells

30 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Functional and molecular characteristics of Na(+)-dependent nucleoside transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Nucleobase transporters (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

A human nucleobase transporter-like cDNA (SLC23A1): member of a transporter family conserved from bacteria to mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Systematic variation in gene expression patterns in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

A gene expression database for the molecular pharmacology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

An information-intensive approach to the molecular pharmacology of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

Nucleoside transport in normal and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1359-4117.2002.01035.X

10.1046/J.1359-4117.2002.01035.X

21 January 2018

Identifiers

DOI

1 reference

release_nqhemdzebndxtp35epchtpxqzq

30 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nqhemdzebndxtp35epchtpxqzq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference